Valentin Popov

Devyser receives Eurostars grant to develop novel DNA test for early detection of transplant rejection

Devyser has been awarded a funding of EUR 750,000 through the Eurostars-2 program and will join its efforts with the University Hospital of Zurich to further develop its unique NGS based test for early detection of kidney transplant recipients. Through this project, Devyser aims to provide a certified CE-IVD kit, including reagents, protocols and software …

Devyser receives Eurostars grant to develop novel DNA test for early detection of transplant rejection Read More »

Case Study – A new NGS-based method for chimerism monitoring

New methods for mixed chimerism analytics are transforming post-transplant monitoring, enabling earlier detection of relapse and initiation of treatment to improve and save the lives of transplanted patients. Dr. Dan Hauzenberger, Medical Director, Section of Transplantation Immunology at Sweden’s Karolinska University Hospital, shares why Karolinska decided to replace their STR-PCR and qPCR methods with a …

Case Study – A new NGS-based method for chimerism monitoring Read More »

Major health care providers in Latin America implement Devyser’s solutions to improve post-transplant healthcare management

IMSS, Mexico’s largest public health care provider and INP, Mexico’s National Institute of Pediatrics, now use Devyser’s solutions for chimerism monitoring of transplanted patients Stockholm 13 October 2020 – Devyser’s solutions are implemented in routine testing at Mexico’s largest public health care provider, IMSS, and Mexico’s National Institute of Pediatrics, INP. Both centers will be …

Major health care providers in Latin America implement Devyser’s solutions to improve post-transplant healthcare management Read More »

Devyser at DGTI 2020

Come and visit our virtual booth at DGTI! The 53rd annual meeting in Immunohaematology and Transfusion Medicine is taking place virtually from September 16th to 18th 2020. Visit our virtual booth to learn more about our upcoming solution for the non-invasive detection of fetal RHD status as well as Devyser Chimerism, our chimerism monitoring solution. …

Devyser at DGTI 2020 Read More »

Discover Devyser CFTR 68

https://vimeo.com/434385139/77bd5832b6 Discover Devyser CFTR 68, our latest kit for the analysis of the CFTR gene, capable of detecting up to 68 mutations most commonly associated with Cystic Fibrosis. List of mutations detected by Devyser CFTR 68 711+ 1G>T, 2043delG, 1677delTA, W1282X, R1283M, K710X, 3849+10kbC>T, 2789+5G>A, M1101K, G85E, 3905insT, 1525-1G>A, 2184delA, 3659delC, N1303K, 2184insA, 1812-1G->A, CFTRdele2,3, …

Discover Devyser CFTR 68 Read More »

Join our Q&A Poster viewings at the ESHG 2020 Virtual Conference!

The Q&A Poster viewing sessions at ESHG 2020 Virtual Conference will highlight two of our products: Devyser RHD, a non-invasive risk screening kit for RhD-negative mothers and Devyser Thalassemia, a single-tube NGS kit for Thalassemia detection. Devyser RHD Sunday, June 7th – 13.00 – 13.45 CEST P01.109.A: “A fast and non-invasive method for fetal RHD …

Join our Q&A Poster viewings at the ESHG 2020 Virtual Conference! Read More »